CrossrefInfokarte
Real-World Impact of Tezepelumab on Asthma Exacerbations, Healthcare Resource Utilization, and Costs in US Patients with Severe Asthma: CROSSROADS-1
Journal of Asthma and Allergy · 2026-10 · Volume 19 · 1-15
DOI: 10.2147/jaa.s620862 ↗Abstract
Kein Abstract verfügbar.
EUVIMED